F8 and hemophilia A: In this study, we explored the possibility of a universal gene-correction strategy in which the human EF1α promoter-driven FVIII gene is expressed in the FVIII locus of hemophilia A patient-derived iPSCs by using a CRISPR/Cas9-mediated donor plasmid knock-in.